Title: BDNF: Role in Synaptic Plasticity, Learning, and Memory
1BDNF Role in Synaptic Plasticity, Learning, and
Memory
- Abby Suelflow
- 9 April 2010
2BDNF Basics
- Distributed in many regions of adult brain
- Multiple BDNF transcripts that encode exact same
protein - BDNF promotors involved in various processes
- Role in synaptic modulation recognized in late
1990s. - Regulation of synaptic transmission and
plasticity and role in neuronal survival - Leads to changes in neuronal circuitry by
altering number and/or strength of synaptic
connections.
3Regulation by Neuronal Activity
- Interactions between BDNF and neuronal activity
helps regulate complicated cognitive functions - Circadian rhythms and fear emotion
- Learning and exercise
- Conditions w/ altered neuronal activity
- Regulation of cellular processes
4Cell Biology of BDNF
- P75 neurotrophin receptor (p75NTR)
- Promotes apoptosis
- Tropomyocin-related receptor tyrosine kinase
(Trk) receptors (high affinity). - Promotes cell survival
5p75NTR activation
- Intracellular transduction cascades activated
- NT-?B
- Jun Kinase
- Sphingomyelin hydrolysis
- Initiation of apoptosis (LTD)
6Processing and Trafficking Overview
(majority)
7Val66met polymorphic substitution
- Val-BDNF
- Cell body
- Dendrites
- synapses
- Met-BDNF
- Cell body
- Proximal dendrites
- Rarely at distal dendrites
- Absent at synapses
8ProBDNF mBDNF
- Elicit opposite effects on synaptic plasticity.
9Input Specificity
- BDNF actions are local and synapse-specific
- Activity dependent
- Limited capacity of diffusion due to negative
charge - BDNF exon II and IV transcripts can be targeted
into dendrites of hippocampal neurons - Ensure better response of target synapses to BDNF
by regulating TrkB trafficking
10Roles of BDNF in LTP
- E-LTP
- Short-lasting (1h)
- Depends on protein phosphorylation
- BDNF/TrkB mutations lead to impairments
- Reversed by acute application of recombinant BDNF
- L-LTP
- Last many hours
- Requires new protein synthesis
- Requires tPA and plasmin (proteases)
11(No Transcript)
12Learning, Memory, and Other Cognitive Functions
- BDNF regulation of learning and memory
- Spatial learning significantly impaired when BDNF
signaling is disrupted. - BDNF/TrkB deletions lead to a decrease of
contextual fear or spatial memories and
hippocampal LTP.
13Learning Models in Rats
- BDNF expression increased in hippocampus of rats
after the following tests - Morris Water Maze (MWM)
- Radial arm maze
- Passive avoidance/contextual fear conditioning
- Gene ablation of BDNF or TrkB results in learning
impairments.
14Carla Cunha et al. (2009)
- Brain-derived neurotropic factor (BDNF)
overexpression in the forebrain results in
learning and memory impairments
15Learning Paradigms
- Accelerating Rota-Rod
- Rotating cylinder covered with rubber
- Speeds increasing from 4-40 rpm over 6 mins.
16- Locomotor Activity
- Contained UV photoelectric beams
- Measured horizontal and vertical movements
measured by total number of beam disruptions
during 10 minute period.
17- Passive Avoidance
- Illuminated white compartment and black dark
chamber permitting passage of electric foot
shocks. - 2 different conditions
- White compartment 2X black compartment (10.0s)
- White compartment black compartment (3.0s)
18http//www.youtube.com/watch?vzBNoNoEB1X0
- Eight-arm radial maze
- Scored total number of errors (re-entering a
previously visited arm) and total number of
correct visits. - One trial per day for 12 consecutive days
19- Morris Water Maze (MWM) (hidden platform)
- Trained to swim to platform in 2 daily trials,
with 30 minute interval, during 10 consecutive
days. - Probe trials- hidden platform removed and
swimming path recorded. - Measured latency to reach platform (s), total
distance swam to the platform (cm), and average
swim speed (cm/s).
20Transgenic mice overexpress mature BDNF in most
forebrain regions
2.0
1.8
3.3
2.8
2.4
No difference
Transgenic mice Higher BDNF immunoreactivity in
all forebrain structures analyzed in comparison
to WT. WT (n10) and BDNF (n10) mice
21Western Blot Analysis
- Antibodies recognizing p32 proBDNF
- No significant differences b/t genotypes for all
structures
WT n3, BDNF n3
22Measurement of Body Weight
- 35 WT and 30 BDNF males
- WT 27.47 0.76 g
- BDNF 25.74 0.58 g
- Results no significant difference in reduction
of body weight for transgenics.
23Motor Performance of Transgenic Mice
Both groups showed a significant improvement in
motor coordination over time.
Similar performances in both directions no
differences in spontaneous exploratory behavior.
24Passive Avoidance TaskSTM/LTM
BDNF transgenics manifest impairments in
long-term memory formation preserved up to 10
days from learning.
Impairments result of both short and long-term
deficits in forming and stabilizing the memory
trace.
25Assessment of Spatial Memory in the 8-Arm Radial
Maze Task
- Measured of correct visits, of errors,
latency to complete the task.
26Behavioral Performance Measure
27Assessment of Spatial Memory MWM Task
BDNF transgenics generally slower reaching target
platform
BDNF transgenics had to swim a longer distance to
reach platform
Significant decrease in mean velocity through the
test
28Probe Trials (5 10 days)
29Time Spent on Platform Zone
30Summary of Results
- BDNF overexpression in forebrain regions leads to
clear learning impairments in instrumental and
spatial memory tasks. - BDNF transgenics can learn the task but have
apparent mild spatial memory impairments - Passive Avoidance analysis revealed deficit in
acquisition of STM not a true deficit in memory
consolidation. - BDNF mice have a significant retarded acquisition
in the MWM test (consistent with 8-arm memory
impairment results)
31Why the Detrimental Effects?
- Anxiety-like behavior present in this BDNF line
- Ratio of pro/mature BDNF in favor of pro form.
- Hyperactivation of p75 receptors
- Decreased activation of TrkB receptors
- Not a likely possibility
32More Plausible Explanation
- Excess mature BDNF acts on inhibitory
interneurons - TrkB receptors found in number of forebrain
interneurons - Functions attributed to BDNF in non pyramidal
cells
33(No Transcript)
34Future Clinical Use
- Potential therapeutic molecule for
- Parkinsons
- Huntingtons
- Depression
- Substance abuse